expert reaction to comments by Elon Musk about use of ketamine for depression
Scientists react to Elon Musk claiming that he used ketamine for depression. Dr Rupert McShane, Consultant Psychiatrist at Oxford … read more
Scientists react to Elon Musk claiming that he used ketamine for depression. Dr Rupert McShane, Consultant Psychiatrist at Oxford … read more
A study published in Nature Neuroscience suggests that psychedelics promote plasticity by directly binding to BDNF receptor TrkB. Dr … read more
Millions of people around the world are prescribed antidepressants to treat chronic pain. In many countries, including the UK, regulators … read more
A meta-analysis published by Cochrane looks at the use of antidepressants for pain management in adults with chronic pain. This … read more
A study published in PNAS suggests that antidepressants can induce mutation and enhance persistence towards multiple antibiotics. The following … read more
The National Institute for Health and Care Excellence (NICE) have published a new draft quality standard on treatment of depression. … read more
A study published in JAMA Internal Medicine looks at antidepressant use during pregnancy and risk of neurodevelopmental disorders in children. … read more
A review paper published in Molecular Psychiatry looks at the ‘serotonin theory of depression’. Prof Gitte Moos Knudsen, Professor … read more
A study published in PLOS ONE looks at antidepressants and health-related quality of life (HRQoL) for patients with depression. … read more
An observational study published in JAMA Network Open looks at mortality risk among patients with COVID-19 prescribed selective serotonin reuptake … read more
A new study has looked at the impact of coming off antidepressants in those who have been taking them long … read more
A study published in New England Journal of Medicine (NEJM) looks at maintenance or discontinuation of antidepressants in primary care. … read more
This phase 2 trial is the first head to head comparison of psilocybin against a licenced antidepressant in patients with … read more
A study published in the New England Journal of Medicine looks at phase 2 trail comparing psilocybin, the active compound … read more
The National Institute of Health and Care Excellence (NICE) have announced a second public consultation on its draft guidance which … read more
NICE have issued their draft guidance on Esketamine nasal spray for treatment resistant depression. Dr Paul Keedwell, Consultant Psychiatrist, … read more
A study, published in the journal eneuro, reports on the impact on offspring of SSRI medication use in mouse pregnancy. … read more
A study, published in JAMA Psychiatry, examined the existing evidence on antidepressants and links to negative health outcomes. Dr … read more
SSRI antidepressants, such as sertraline, are the most commonly prescribed forms of antidepressants in the UK. Public concern, both about … read more
A study, published in Lancet Psychiatry, reports that the antidepressant sertraline may reduce anxiety more than depressive symptoms. This … read more